BioStem Technologies launches $3M private placement at $4.08 per share

BioStem Technologies Inc. (NASDAQ: BSEM) has entered into definitive agreements for a $3 million private placement, according to a company statement.

The offering consists of 735,296 shares of common stock priced at $4.08 per share, along with two series of warrants — Series A and Series B — each covering up to 735,296 shares. Both warrant series carry an exercise price of $3.83 per share and are exercisable immediately upon issuance.

Series A warrants expire five years after the effective date of the resale registration statement, while Series B warrants expire 24 months after that date. If both warrant series are exercised in full for cash, the company would receive additional gross proceeds of approximately $5.6 million. The company noted there is no assurance the warrants will be exercised.

The offering is expected to close on or about September 30, 2026, subject to customary closing conditions. Net proceeds are intended for working capital and general corporate purposes.

H.C. Wainwright & Co. is acting as exclusive placement agent for the offering.

The securities are being offered under Section 4(a)(2) of the Securities Act of 1933 and Regulation D and have not been registered with the SEC. BioStem has agreed to file one or more resale registration statements with the SEC covering shares issued in the offering and shares issuable upon warrant exercise.

You May Also Be Interested In

• Ives Ultra AI Opportunities prices $200M IPO on NYSE
• Atlantic HPC acquires 29 MW power site in Tennessee
• AIxCrypto Holdings rebrands as FF EAI Robotics Ecosystem, ticker FFR